Compare SPT & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPT | EOLS |
|---|---|---|
| Founded | 2010 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.7M | 500.0M |
| IPO Year | 2019 | 2018 |
| Metric | SPT | EOLS |
|---|---|---|
| Price | $12.69 | $7.41 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 6 |
| Target Price | $10.67 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 714.3K | 611.3K |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.11 | 1.23 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $457,547,000.00 | $297,176,000.00 |
| Revenue This Year | $8.10 | $12.44 |
| Revenue Next Year | $6.01 | $17.37 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 12.72 | 11.61 |
| 52 Week Low | $4.92 | $3.86 |
| 52 Week High | $12.73 | $9.31 |
| Indicator | SPT | EOLS |
|---|---|---|
| Relative Strength Index (RSI) | 71.60 | 44.23 |
| Support Level | $9.08 | $7.07 |
| Resistance Level | N/A | $7.83 |
| Average True Range (ATR) | 0.51 | 0.32 |
| MACD | 0.21 | -0.02 |
| Stochastic Oscillator | 94.39 | 44.17 |
Sprout Social Inc develops a cloud software that brings together social messaging, data and workflows in a unified system of record, intelligence, and action. It has a centralized, secure and powerful platform that can scale horizontally across an organization to drive maximum business value. The firm generates majority revenue from software subscriptions. Geographically, the company operates in Americas, EMEA, and Asia Pacific, of which it derives maximum revenue from Americas.
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.